Last updated: April 17, 2025
Sponsor: University of Saskatchewan
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Placebo
Ashwagandha
Clinical Study ID
NCT06900569
2024_25_06
Ages 18-35 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: male or female, aged 18-35y
Exclusion
- Exclusion Criteria:
Conditions that may be affected by exercise (determined by "yes" answers to the "Get Active Questionnaire") Pregnant Breastfeeding
Allergies to:
Dicalcium Phosphate
Cellulose
Vegetable magnesium stearate
Silica
Study Design
Total Participants: 20
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
March 22, 2025
Estimated Completion Date:
May 15, 2025
Study Description
Connect with a study center
University of Saskatchewan
Saskatoon, Saskatchewan S7K 2X2
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.